Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
21 February 2014 09:50
Clinical trials were carried out in vivo as well as in vitro
A new drug which selectively kills dormant cancer cells has been tested by scientists.
The molecule works by inducing dysfunction in mitochondria - the powerhouse of cells.
The research, conducted by Prof Stig Linder of the Swedish Karolinska Instituet and Uppsala University, found that a small molecule named VLX600 has been proven ineffective in killing dormant colon cancer cells in a variety of models, including in clinical trials and in test subjects with the medical condition.
Experts say that in solid tumours larger than a few millimetres, a lack of oxygen and nutrients is common as a result of insufficient growth in the blood vessels. This can cause cancer cells to remain dormant - and even after they receive treatment, they can divide, causing tumours to grow. This process helps cancers resist radiotherapy and chemotherapy.
The study shows that in these tumour areas that lack oxygen and nutrition, there is a lack of mitochondrial energy production for which the cancer cells cannot compensate. The researchers said: "Our ?ndings suggest that tumour cells in nutritionally compromised microenvironments are sensitive to disturbances of mitochondrial function, resulting in a bioenergetic catastrophe."
The VLX600 molecule was found to cause this dysfunction in mitochondria, causing colon cancer cells to die. When the substance was tested on colon cancer cell lines in vivo, it suppressed tumour growth. The molecule also helped boost other anti-cancer drugs, such as irinotecan.
The study leaders said: "Our ?ndings suggest that tumour cells in metabolically compromised microenvironments have a limited ability to respond to decreased mitochondrial function, and suggest a strategy for targeting the quiescent populations of tumour cells for improved cancer treatment."
People can find more information about travel insurance for cancer patients here.
16 August 2018
Holidaymakers in the UK will be hit by more train price hikes from next year, after the Government announced ticket prices will increase by 3.2% in January.
[more...]
15 August 2018
A simple blood test could help GPs detect a rare form of bone marrow cancer much earlier, a new study suggests.
14 August 2018
Passengers arriving at Heathrow Airport last month faced queues of over two and a half hours at passport control, new figures have revealed.
11 August 2018
Hundreds of Ryanair flights will not take off as planned on Friday due to pilot strikes in five countries.
10 August 2018
Fad diets that cut out carbs while increasing fat consumption could lead to an increased risk of diabetes, according to new research.
09 August 2018
HIV testing has become even more accessible after a self-testing kit was made available from a High Street retailer.
08 August 2018
Women patients are more likely to survive a heart attack if they are treated by a female doctor, a new US study has revealed.
07 August 2018
The head of British Airways has branded two-hour queues facing travellers at Heathrow's passport control as a "border farce."
04 August 2018
Simple factors such as gender and body mass can help doctors to personalise care for patients with type 2 diabetes and avoid harmful side effects, according to a study.
03 August 2018
Gatwick Express must no longer claim it runs "non-stop to Victoria station in half an hour" and "in just 30 minutes" unless it can achieve the time in most cases, a watchdog has ruled.
02 August 2018
A charity is calling for greater access to respite support after it emerged that 72% of Britain's 700,000 young carers feel lonely and isolated during the summer holidays.
01 August 2018
A plan to build new rail links with Heathrow Airport and connect Windsor's two train stations have been submitted to the Government.